Maybe I'm crazy, only been a shareholder for a few

Maybe I'm crazy, only been a shareholder for a few months, but NP seems like a bit of a dreamer. We all speculate the added shares are to cover costs because maybe there is no deal coming , or none coming soon, but I had a thought. NP likes to think big, and he talks big too, but his personality wants more. So what if they actually do have a deal almost in place to license that would cover the bills to keep the lights on. The latest filing states the additional shares may be used for financing or acquisitions. Does anyone happen to know the value of IncellDx? Seems to me NP was impressed they could cut down the cost and time it took to identify patients and the levels of pro 140 needed(perhaps other biotechs or pharmas might be interested in these services as well???). IncellDx appears to be private, but I wouldn't put it past NP. Leronlimab is only one drug with multiple indications, wouldn't hurt to expand the moat a bit. Perhaps this could be their next prostagene. Absolute speculation because I have no idea the value of IncellDx.